 |
|
Experimental vaccine protects mice against deadly 1918 flu virus
October 18, 2006Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus. They also have created a technique for identifying antibodies that neutralize this virus, a tool that could help contain future pandemic flu strains. These findings are important, the researchers say, to understanding and preventing the recurrence of the H1N1 influenza virus that caused the 1918 pandemic and to protecting against virulent flu strains in the future, including the H5N1 avian flu virus. Details of the research are available online this week in Proceedings of the National Academy of Sciences.
Gary J. Nabel, M.D., Ph.D., director of the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), led the research team in developing the experimental vaccines and conducting the immunological studies in mice. Terrence Tumpey, Ph.D., of the Centers for Disease Control and Prevention (CDC) conducted vaccine studies in mice involving the live, reconstructed 1918 flu virus in a biosafety level 3-enhanced laboratory at the CDC in Atlanta-one of four types of specialized biosafety labs where scientists study contagious and potentially deadly materials under high-level safety and contamination precautions designed to protect the researchers and prevent microorganisms from entering the environment.
"Understanding why this influenza virus was so deadly is an extremely important question," says NIAID Director Anthony S. Fauci, M.D. "By building upon earlier research where scientists successfully reconstructed the 1918 pandemic flu strain, Dr. Nabel and his colleagues have demonstrated that this virus is vulnerable to intervention. This knowledge will help further our continued efforts to develop treatments and vaccines to protect us against another deadly flu pandemic."
The 1918-1919 influenza pandemic was the most deadly flu outbreak in modern history, killing 50 million or more people worldwide.
"A key to containing pandemic flu viruses is to understand their vulnerabilities and determine whether they can evade immune recognition," says Dr. Nabel. "What we learn about the H1N1 virus that caused the 1918 pandemic is pertinent to other pandemic viruses and to the development of effective and universal vaccines."
Using the genetic sequence information for the 1918 flu virus, Dr. Nabel and his VRC colleagues created plasmids-small strands of DNA designed to express specific characteristics-carrying genes for the virus' hemagglutinin (HA) protein, the surface protein found in all flu viruses that allows the virus to stick to a cell and cause infection. The researchers created two types of plasmids: one to reflect the HA found in the original 1918 flu virus; the other an altered HA protein designed to attenuate (weaken) the virus.
Mice were then injected with a DNA vaccine containing both types of plasmids to determine whether they would generate immune responses to the 1918 virus. The researchers found significant responses both in terms of production of T-cells, the white blood cells critical in the immune system's battle against invading viruses, as well as the production of neutralizing antibodies.
To determine the vaccine's protective effects, the CDC's Dr. Tumpey intranasally exposed a group of mice to live, reconstructed 1918 virus 14 days after they were immunized with the experimental DNA vaccine. All 10 vaccinated mice survived the challenge with the deadly virus. To explore how the vaccine protected the animals, the researchers first depleted other mice of T-cells; however, this had no effect on the immunity of the vaccinated mice to the 1918 virus. In contrast, the researchers discovered that transferring antibody-rich immunoglobulin (IgG) from immunized mice to non-immunized mice resulted in antibody levels in the animals at levels only slightly lower than those that were immunized. Further, when the animals were exposed to the reconstructed 1918 flu virus, 8 of 10 mice that received antibodies from the immunized mice survived; none of the 10 mice that received IgG from the unvaccinated control group survived.
"By using an existing pandemic flu strain, this research will provide the basis for design of alternative vaccines against influenza viruses with enhanced virulence," says Dr. Tumpey.
Although the researchers are not discounting the potential role T-cells may have in combating flu viruses, they concluded that in this study, the experimental DNA vaccine protected the mice by stimulating antibodies capable of neutralizing the 1918 flu virus.
"Who would have imagined five years ago that we'd be able to create a vaccine that protects against one of the deadliest forms of influenza the world has ever seen?" adds Dr. Nabel. "It's because the 1918 flu virus has been reconstructed that we are now able the further understand it. Hopefully, this virus will help us to develop effective vaccine strategies for current pandemic influenza virus threats."
To evaluate the vaccine's antibody-inducing capabilities while minimizing exposure of lab personnel to the 1918 flu virus, Dr. Nabel and his VRC colleagues also created artificial viruses, or pseudoviruses, featuring the HA of the 1918 flu virus but stripped of the ability to cause infection. The pseudoviruses were then incubated with antibody-containing blood samples from the mice immunized with the DNA vaccine and those that were not. The researchers found that the antibodies from the immunized mice neutralized the pseudoviruses while the blood samples from the mice that were not immunized had no effect. This method was also effective in identifying neutralizing antibodies to the H5N1 avian flu virus and could be used to screen for monoclonal antibodies that may be used as an antiviral treatment, according to Dr. Nabel.
"This technique would be very useful in defining evolving serotypes of flu viruses like H5N1 to develop immune sera and neutralizing monoclonal antibodies that may help to contain pandemic flu," says Dr. Nabel.
The study authors indicate that further testing will be needed to determine whether DNA vaccination can confer immune protection in people similar to that seen in the study mice. Additionally, the use of DNA-based vaccines are being explored as a potential strategy for creating vaccines to protect against the H5N1 avian flu virus.
NIH/National Institute of Allergy and Infectious Diseases
The 1918-1919 influenza pandemic was the most deadly flu outbreak in modern history, killing 50 million or more people worldwide.
"A key to containing pandemic flu viruses is to understand their vulnerabilities and determine whether they can evade immune recognition," says Dr. Nabel. "What we learn about the H1N1 virus that caused the 1918 pandemic is pertinent to other pandemic viruses and to the development of effective and universal vaccines."
Using the genetic sequence information for the 1918 flu virus, Dr. Nabel and his VRC colleagues created plasmids-small strands of DNA designed to express specific characteristics-carrying genes for the virus' hemagglutinin (HA) protein, the surface protein found in all flu viruses that allows the virus to stick to a cell and cause infection. The researchers created two types of plasmids: one to reflect the HA found in the original 1918 flu virus; the other an altered HA protein designed to attenuate (weaken) the virus.
Mice were then injected with a DNA vaccine containing both types of plasmids to determine whether they would generate immune responses to the 1918 virus. The researchers found significant responses both in terms of production of T-cells, the white blood cells critical in the immune system's battle against invading viruses, as well as the production of neutralizing antibodies.
To determine the vaccine's protective effects, the CDC's Dr. Tumpey intranasally exposed a group of mice to live, reconstructed 1918 virus 14 days after they were immunized with the experimental DNA vaccine. All 10 vaccinated mice survived the challenge with the deadly virus. To explore how the vaccine protected the animals, the researchers first depleted other mice of T-cells; however, this had no effect on the immunity of the vaccinated mice to the 1918 virus. In contrast, the researchers discovered that transferring antibody-rich immunoglobulin (IgG) from immunized mice to non-immunized mice resulted in antibody levels in the animals at levels only slightly lower than those that were immunized. Further, when the animals were exposed to the reconstructed 1918 flu virus, 8 of 10 mice that received antibodies from the immunized mice survived; none of the 10 mice that received IgG from the unvaccinated control group survived.
"By using an existing pandemic flu strain, this research will provide the basis for design of alternative vaccines against influenza viruses with enhanced virulence," says Dr. Tumpey.
Although the researchers are not discounting the potential role T-cells may have in combating flu viruses, they concluded that in this study, the experimental DNA vaccine protected the mice by stimulating antibodies capable of neutralizing the 1918 flu virus.
"Who would have imagined five years ago that we'd be able to create a vaccine that protects against one of the deadliest forms of influenza the world has ever seen?" adds Dr. Nabel. "It's because the 1918 flu virus has been reconstructed that we are now able the further understand it. Hopefully, this virus will help us to develop effective vaccine strategies for current pandemic influenza virus threats."
To evaluate the vaccine's antibody-inducing capabilities while minimizing exposure of lab personnel to the 1918 flu virus, Dr. Nabel and his VRC colleagues also created artificial viruses, or pseudoviruses, featuring the HA of the 1918 flu virus but stripped of the ability to cause infection. The pseudoviruses were then incubated with antibody-containing blood samples from the mice immunized with the DNA vaccine and those that were not. The researchers found that the antibodies from the immunized mice neutralized the pseudoviruses while the blood samples from the mice that were not immunized had no effect. This method was also effective in identifying neutralizing antibodies to the H5N1 avian flu virus and could be used to screen for monoclonal antibodies that may be used as an antiviral treatment, according to Dr. Nabel.
"This technique would be very useful in defining evolving serotypes of flu viruses like H5N1 to develop immune sera and neutralizing monoclonal antibodies that may help to contain pandemic flu," says Dr. Nabel.
The study authors indicate that further testing will be needed to determine whether DNA vaccination can confer immune protection in people similar to that seen in the study mice. Additionally, the use of DNA-based vaccines are being explored as a potential strategy for creating vaccines to protect against the H5N1 avian flu virus.
NIH/National Institute of Allergy and Infectious Diseases
Flu Virus Current Events and Flu Virus News RSSPushing light beyond its known limits
Scientists at the University of Adelaide have made a breakthrough that could change the world's thinking on what light is capable of.
When should flu trigger a school shutdown?
As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down?
Scientists discover influenza's Achilles heel: Antioxidants
As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants.
NIAID scientists propose new explanation for flu virus antigenic drift
Influenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein.
TGen seeks emergency FDA approval of new swine flu test
The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus.
Lessons from flu seasons past
Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.
Triple-Combo Drug Shows Promise Against Antiviral-Resistant Swine Flu, UAB Researcher Says
An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.
Paradigm shift needed to combat drug resistance
When people travel, bacteria and other infectious agents travel with them. As about a billion people cross international borders each year, many more billions of the bugs come along for the ride.
Flu surveillance boosts control, treatment options, says UAB travel-clinic chief
Because pandemics unfold in unpredictable ways, surveillance of travel-related illness is among the most powerful tools health officials and doctors can use to detect and respond to new pathogens like the novel H1N1 influenza, says the physician who heads the University of Alabama at Birmingham (UAB) Travelers' Clinic.
NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma
The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.
More Flu Virus Current Events and Flu Virus News Articles
 |
Bird Flu: A Virus of Our Own Hatching by Michael Greger (Author) From age-old scourges such as smallpox and tuberculosis to emerging threats like AIDS and SARS, our interactions with animals have always played a pivotal role as a source of human disease. Bird flu is the latest such menace coming home to roost. Leading public health authorities now predict as inevitable a pandemic of influenza, triggered by bird flu and expected to lead to millions of deaths around the globe. The influenza virus has existed for millions of years as an innocuous intestinal virus of wild ducks. What turned a harmless waterborne duck virus into a killer? In Bird Flu, Dr. Michael Greger traces the human role in the evolution of this virus, whose humble beginnings belie its transformation into a killer mutant strain with the potential to become as ... |
 |
Error: 27A Virus Alert - Your computer has the flu. Ladies T-Shirt Pink Large by T-ShirtFrenzy The Design/Saying is printed on the front of this T-Shirt, we use the newest & best technology to print the design with great inks that are cured into the product. This new high tech way of producing garments is very fade resistant. WE DO NOT USE TRANSFERS. It is great, since you dont have that thick transfer feeling. The feel is very smooth and comfortable. T-ShirtFrenzy offers over 30,000 designs on tons of products to offer millions of variations. You can search our store for something for everyone on your gift list or shop for yourself (our personal favorite). Please contact us with questions. |
 |
Killer Virus: Hunt For The Next Plague There is a strange and deadly new virus in Asia, and it claims the lives of nearly 50% of its victims. A team of virus hunters travels to Bangladesh, the latest front in the battle against the recently-discovered Nipah virus, to capture the puppy-sized bats that are believed to be the source of this frightening killer. We'll also trace the evolution of AIDS, SARS, West Nile, the Spanish Flu and the Avian Flu - all diseases that made the jump from animal to human, and then human to human. Increasingly, our global progress is itself a factor that helps these viruses to become resilient. What seems exotic and distant in Africa or Asia today could arrive on our doorsteps tomorrow. Is Nipah the next epidemic? This product is manufactured on demand using DVD-R recordable media. Amazon.com's... |
 |
The Handler by MAKER ENTERPRIES A new low-tech product made from high-tech materials, the Handler anti-microbial handheld door opening device becomes one of the first truly practical tools designed to help individuals fight the perennial battle against infectious diseases. It does so by breaking the cycle of transmission and leaving the dreaded culprits at the door -- literally. The Centers for Disease Control (CDC) tell us that common colds, flus and staph infections, to name a few, are often transmitted as a result of intimate contact with carriers as well as contact with common surfaces that we share with them. As a first line of defense, the Handler, which fits conveniently on your key-chain, is a handheld device with a deployable gripping arm that allows users to interact with the most egregious of disease... |
 |
Lysol 4 in 1 Disinfecting Wipes Kills Flu Virus, Citrus Scent - 35 Wipes/bottle, 12 Ea by Lysol Disinfecting Wipes INDICATIONS: Lysol 4 In 1 Disinfecting Wipes Kills Flu Virus, Citrus Scent Strong wipe for your challenging messes. Kills 99.9% of germs. Tough on messes. For use in the kitchen and bathroom. Strong wipe. Citrus Scent. |
 |
Alternative Health & Herbs Remedies Cold/Flu Virus 2 Ounces (Pack of 2) by Alternative Health & Herbs Remedies |
 |
Flu Birds Starring: Sarah Butler, Clare Carey, Serban Celea, Gabriel Costin, Lance Guest Directed By: Leigh Scott Also With: Kenneth M. Badish (Producer), Mark Moran (Producer), Brad Southwick (Producer) |
 |
Germ Guardian Personal Air Purifier by Guardian Technologies Breathe healthier air wherever you go. Germ Guardian personal air purifier helps push allergens and pollutants away from you by emitting healthy negative ions. Help keep your family healthy the safe, natural way. Fits easily around your neck or in a shirt pocket, to provide a healthier breathing experience. |
 |
T-5000 P95 Disposable Respirator - Filters: virus, bacteria, fungi and odors by Union Springs Pharmaceuticals The T-5000 series P-95 disposable respirators with Triosyn antimicrobial protection reduce exposure to airborne particles that may contain microorganisms. The T-5000 offers a secure and comfortable fit for almost every face, proection for 8 - 12 hours, and a charcoal layer that filters smoke and powerful odors. |
 |
Pocket Pals Instant Spray Hand Sanitizer 2/2 Pack by Enper Kills 99.99% of most common germs that can make you sick-62% ethyl alcohol. Contains moisturizing aloe vera; goes on smooth, dries fast, no stick mess. Pleasant fresh scented fragrance delivered via fine mist spray. Convenient-store in purse, backpack, travel bag, etc. Use on the go...anytime/anywhere...school, work, play, etc. Over 70 sprays per bottle, 140 per 2 pack, equivalent to 6.5 ounces of hand sanitizer gel. |
| © 2009 BrightSurf.com |